$5.10
-0.35-6.42%
In chiusura: -
$4.92
-0.18-3.53%
After hour: 7:58 PM EDT
Tieni traccia delle ultime attività di insider trading ATAI Life Sciences. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni ATAI Life Sciences.
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Aug 18, 2025 | — | 8.68M | $2.19 | $19.00M | BUY | 19.64% | 52.84M | Aug 14 | ||
Mar 24, 2025 | CHIEF BUSINESS OFFICER | -48.56K | $1.35 | -$65.56K | SELL | -29.58% | 115.64K | Mar 21 | ||
Mar 24, 2025 | CHIEF MEDICAL OFFICER | -11.56K | $1.35 | -$15.61K | SELL | -57.82% | 8.44K | Mar 21 | ||
Mar 24, 2025 | SEE REMARKS | -75.42K | $1.35 | -$101.81K | SELL | -25.84% | 216.44K | Mar 21 | ||
Mar 24, 2025 | CHIEF FINANCIAL OFFICER | -33.55K | $1.35 | -$45.29K | SELL | -19.32% | 140.04K | Mar 21 | ||
Mar 24, 2025 | CHIEF SCIENTIFIC OFFICER | -13.16K | $1.35 | -$17.77K | SELL | -23.72% | 42.33K | Mar 21 | ||
Mar 24, 2025 | — | 1.80M | $1.40 | $2.52M | BUY | 4.25% | 44.17M | Mar 24 | ||
Feb 19, 2025 | — | 10.84M | $2.10 | $22.76M | BUY | 34.38% | 42.35M | Feb 14 | ||
May 20, 2024 | SEE REMARKS | -151.30K | $1.92 | -$290.50K | SELL | -31.37% | 331.03K | May 16 | ||
Apr 04, 2024 | CHIEF FINANCIAL OFFICER | -27.41K | $1.85 | -$50.71K | SELL | -27.14% | 73.59K | Apr 02 | ||
Apr 04, 2024 | SEE REMARKS | -61.64K | $1.85 | -$114.03K | SELL | -34.53% | 116.86K | Apr 02 | ||
Apr 04, 2024 | CHIEF BUSINESS OFFICER | -35.80K | $1.85 | -$66.23K | SELL | -35.80% | 64.20K | Apr 02 | ||
Nov 20, 2023 | SEE REMARKS | 20.00K | $1.16 | $23.12K | BUY | 17.80% | 132.33K | Nov 16 | ||
Sep 14, 2023 | SEE REMARKS | 40.00K | $1.45 | $57.97K | BUY | 55.30% | 112.33K | Sep 13 | ||
Mar 30, 2023 | SEE REMARKS | 70.00K | $1.48 | $103.56K | BUY | 3000.43% | 72.33K | Mar 29 | ||
Mar 29, 2023 | 10% OWNER | 1.21M | $1.32 | $1.60M | BUY | 3.72% | 33.89M | Mar 29 | ||
May 03, 2022 | 10% OWNER | 136.39K | $5.02 | $684.55K | BUY | 9.22% | 1.61M | Apr 20 - Apr 21 | ||
May 02, 2022 | 10% OWNER | 56.60K | $4.46 | $252.49K | BUY | 3.25% | 1.80M | Apr 28 - Apr 29 | ||
Apr 28, 2022 | 10% OWNER | 66.01K | $4.67 | $308.57K | BUY | 3.94% | 1.74M | Apr 26 - Apr 27 | ||
Apr 26, 2022 | 10% OWNER | 61.78K | $4.82 | $297.80K | BUY | 3.83% | 1.68M | Apr 22 - Apr 25 | ||
Apr 20, 2022 | 10% OWNER | 119.64K | $5.12 | $612.40K | BUY | 8.80% | 1.48M | Apr 18 - Apr 19 | ||
Apr 18, 2022 | 10% OWNER | 4.97K | $5.19 | $25.78K | BUY | 0.37% | 1.36M | Apr 14 | ||
Apr 14, 2022 | 10% OWNER | 55.20K | $4.88 | $269.56K | BUY | 4.25% | 1.35M | Apr 12 | ||
Apr 12, 2022 | 10% OWNER | 111.61K | $4.82 | $538.19K | BUY | 9.40% | 1.30M | Apr 08 - Apr 11 | ||
Jun 24, 2021 | DIRECTOR | 4.67K | $15.00 | $69.99K | BUY | ∞ | 4.67K | Jun 22 | ||
Jun 24, 2021 | DIRECTOR | 4.67K | $15.00 | $69.99K | BUY | ∞ | 4.67K | Jun 22 | ||
Jun 24, 2021 | 10% OWNER | 700.00K | $15.00 | $10.50M | BUY | 3.39% | 21.37M | Jun 22 | ||
Jun 24, 2021 | SEE REMARKS | 3.50K | $15.00 | $52.50K | BUY | ∞ | 3.50K | Jun 22 | ||
Jun 24, 2021 | DIRECTOR | 4.67K | $15.00 | $69.99K | BUY | ∞ | 4.67K | Jun 22 | ||
Jun 24, 2021 | SEE REMARKS | 2.33K | $15.00 | $34.99K | BUY | ∞ | 2.33K | Jun 22 | ||
Jun 24, 2021 | DIRECTOR | 700.00K | $15.00 | $10.50M | BUY | 3.39% | 21.37M | Jun 22 | ||
Jun 24, 2021 | DIRECTOR | 4.67K | $15.00 | $69.99K | BUY | 0.08% | 5.56M | Jun 22 | ||
Jun 24, 2021 | CHIEF FINANCIAL OFFICER | 4.67K | $15.00 | $69.99K | BUY | ∞ | 4.67K | Jun 22 |
Sfoglia insider trading su tutte le azioni.